SARS-CoV-2 Vaccines and Vaccine-Induced Immunity
A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Vaccines and Therapeutic Developments".
Deadline for manuscript submissions: closed (29 February 2024) | Viewed by 221
Special Issue Editors
Interests: vaccines to prevent viral infections; immunity to viruses; mechanisms of antibody-based protection
Interests: molecular basis of coronavirus pathogenesis; coronaviruses relevant for human and animal health
Special Issue Information
Dear Colleagues,
In this Special Issue entitled ‘SARS-CoV-2 Vaccines and Vaccine-Induced Immunity’, we focus on scientific work related to the immune responses elicited by the current SARS-CoV-2 vaccines used worldwide, and novel vaccine candidates. We are highly interested in the following topics: the humoral responses, including antibody characterization at the monoclonal and polyclonal levels and cellular immunity; however, this is not exclusive. The main goal is to build a concise collection that adds to the current knowledge of how SARS-CoV-2 vaccines work and provide insights into the next-generation SARS-CoV-2 vaccines.
Dr. Juan Manuel Carreño
Dr. Sonia Zuñiga
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- current and novel SARS-CoV-2 vaccines
- neutralizing and non-neutralizing antibodies
- cellular immunity
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
